Mitochondrial cholesterol import

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1862, Issue 1, 2017, Pages 90-101

  Elustondo, Pia ^a   Martin, Laura A ^a   Karten, Barbara ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Lipid transfer proteins; Membrane contact sites; Mitochondrial cholesterol; STARD1; STARD3; START proteins

Indexed keywords

CHOLESTEROL; FAT DROPLET; LIPID TRANSFER PROTEIN; MITOCHONDRIAL PROTEIN; STAR RELATED LIPID TRANSFER DOMAIN PROTEIN 1; STAR RELATED LIPID TRANSFER PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN;

ARTICLE; CHOLESTEROL TRANSPORT; ENDOPLASMIC RETICULUM; ENDOSOME; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; STEROIDOGENESIS; ANIMAL; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PHOSPHOPROTEINS;

EID: 84994130024     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.08.012     Document Type: Article

References (248)

1. [1] Horvath, S.E., Daum, G., Lipids of mitochondria. Prog. Lipid Res. 52 (2013), 590–614.
2. [2] Bosch, M., Mari, M., Gross, S.P., Fernandez-Checa, J.C., Pol, A., Mitochondrial cholesterol: a connection between caveolin, metabolism, and disease. Traffic 12 (2011), 1483–1489.
3. [3] Garcia-Ruiz, C., Mari, M., Colell, A., Morales, A., Caballero, F., Montero, J., Terrones, O., Basanez, G., Fernandez-Checa, J.C., Mitochondrial cholesterol in health and disease. Histol. Histopathol. 24 (2009), 117–132.
4. [4] Mari, M., Morales, A., Colell, A., Garcia-Ruiz, C., Fernandez-Checa, J.C., Mitochondrial cholesterol accumulation in alcoholic liver disease: role of ASMase and endoplasmic reticulum stress. Redox Biol. 3 (2014), 100–108.
5. [5] Montero, J., Mari, M., Colell, A., Morales, A., Basanez, G., Garcia-Ruiz, C., Fernandez-Checa, J.C., Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death. Biochim. Biophys. Acta 1797 (2010), 1217–1224.
6. [6] Colell, A., Fernandez, A., Fernandez-Checa, J.C., Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J. Bioenerg. Biomembr. 41 (2009), 417–423.
7. [7] Martin, L.A., Kennedy, B.E., Karten, B., Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function. J. Bioenerg. Biomembr., 2014.
8. [8] Ferguson, J.J. Jr., Protein synthesis and Adrenocorticotropin responsiveness. J. Biol. Chem. 238 (1963), 2754–2759.
9. [9] Garren, L.D., Ney, R.L., Davis, W.W., Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo. Proc. Natl. Acad. Sci. U. S. A. 53 (1965), 1443–1450.
10. [10] Simpson, E.R., McCarthy, J.L., Peterson, J.A., Evidence that the cycloheximide-sensitive site of adrenocorticotropic hormone action is in the mitochondrion. Changes in pregnenolone formation, cholesterol content, and the electron paramagnetic resonance spectra of cytochrome P-450. J. Biol. Chem. 253 (1978), 3135–3139.
11. [11] Stevens, V.L., Xu, T., Lambeth, J.D., Cholesterol trafficking in steroidogenic cells. Reversible cycloheximide-dependent accumulation of cholesterol in a pre-steroidogenic pool. Eur. J. Biochem. 216 (1993), 557–563.
12. [12] Clark, B.J., Wells, J., King, S.R., Stocco, D.M., The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269 (1994), 28314–28322.
13. [13] Miller, W.L., Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. J. Mol. Endocrinol. 19 (1997), 227–240.
14. [14] Lin, D., Sugawara, T., Strauss, J.F. III, Clark, B.J., Stocco, D.M., Saenger, P., Rogol, A., Miller, W.L., Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267 (1995), 1828–1831.
15. [15] Caron, K.M., Soo, S.C., Wetsel, W.C., Stocco, D.M., Clark, B.J., Parker, K.L., Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 11540–11545.
16. [16] Sugawara, T., Holt, J.A., Driscoll, D., Strauss, J.F. III, Lin, D., Miller, W.L., Patterson, D., Clancy, K.P., Hart, I.M., Clark, B.J., Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 4778–4782.
17. [17] Tsujishita, Y., Hurley, J.H., Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 7 (2000), 408–414.
18. [18] Lavigne, P., Najmanivich, R., Lehoux, J.G., Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding. Subcell. Biochem. 51 (2010), 425–437.
19. [19] Murcia, M., Faraldo-Gomez, J.D., Maxfield, F.R., Roux, B., Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol. J. Lipid Res. 47 (2006), 2614–2630.
20. [20] Reitz, J., Gehrig-Burger, K., Strauss, J.F. III, Gimpl, G., Cholesterol interaction with the related steroidogenic acute regulatory lipid-transfer (START) domains of StAR (STARD1) and MLN64 (STARD3). FEBS J. 275 (2008), 1790–1802.
21. [21] Ponting, C.P., Aravind, L., START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem. Sci. 24 (1999), 130–132.
22. [22] Iyer, L.M., Koonin, E.V., Aravind, L., Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins 43 (2001), 134–144.
23. [23] Clark, B.J., The mammalian START domain protein family in lipid transport in health and disease. J. Endocrinol. 212 (2012), 257–275.
24. [24] Alpy, F., Tomasetto, C., START ships lipids across interorganelle space. Biochimie 96 (2014), 85–95.
25. [25] Alpy, F., Legueux, F., Bianchetti, L., Tomasetto, C., START domain-containing proteins: a review of their role in lipid transport and exchange. Med. Sci. (Paris) 25 (2009), 181–191.
26. [26] Strauss, J.F. III, Kishida, T., Christenson, L.K., Fujimoto, T., Hiroi, H., START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell. Endocrinol. 202 (2003), 59–65.
27. [27] Alpy, F., Tomasetto, C., MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem. Soc. Trans. 34 (2006), 343–345.
28. [28] Calderon-Dominguez, M., Gil, G., Medina, M.A., Pandak, W.M., Rodriguez-Agudo, D., The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer (START) domain proteins: new players in cholesterol metabolism. Int. J. Biochem. Cell Biol. 49 (2014), 64–68.
29. [29] Letourneau, D., Lefebvre, A., Lavigne, P., LeHoux, J.G., The binding site specificity of STARD4 subfamily: breaking the cholesterol paradigm. Mol. Cell. Endocrinol. 408 (2015), 53–61.
30. [30] Gatta, A.T., Wong, L.H., Sere, Y.Y., Calderon-Norena, D.M., Cockcroft, S., Menon, A.K., Levine, T.P., A new family of StART domain proteins at membrane contact sites has a role in ER-PM sterol transport. Elife, 4, 2015, 10.7554/eLife.07253.
31. [31] Khafif, M., Cottret, L., Balague, C., Raffaele, S., Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in eukaryotes. BMC Bioinf., 15, 2014 (222–2105–15-222).
32. [32] Murley, A., Sarsam, R.D., Toulmay, A., Yamada, J., Prinz, W.A., Nunnari, J., Ltc1 is an ER-localized sterol transporter and a component of ER-mitochondria and ER-vacuole contacts. J. Cell Biol. 209 (2015), 539–548.
33. [33] Arakane, F., King, S.R., Du, Y., Kallen, C.B., Walsh, L.P., Watari, H., Stocco, D.M., Strauss, J.F. III, Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J. Biol. Chem. 272 (1997), 32656–32662.
34. [34] Dyson, M.T., Jones, J.K., Kowalewski, M.P., Manna, P.R., Alonso, M., Gottesman, M.E., Stocco, D.M., Mitochondrial A-kinase anchoring protein 121 binds type II protein kinase A and enhances steroidogenic acute regulatory protein-mediated steroidogenesis in MA-10 mouse leydig tumor cells. Biol. Reprod. 78 (2008), 267–277.
35. [35] Pon, L.A., Hartigan, J.A., Orme-Johnson, N.R., Acute ACTH regulation of adrenal corticosteroid biosynthesis. Rapid accumulation of a phosphoprotein. J. Biol. Chem. 261 (1986), 13309–13316.
36. [36] Epstein, L.F., Orme-Johnson, N.R., Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 266 (1991), 19739–19745.
37. [37] Stocco, D.M., Kilgore, M.W., Induction of mitochondrial proteins in MA-10 Leydig tumour cells with human choriogonadotropin. Biochem. J. 249 (1988), 95–103.
38. [38] Stocco, D.M., Clark, B.J., Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem. Pharmacol. 51 (1996), 197–205.
39. [39] Arakane, F., Sugawara, T., Nishino, H., Liu, Z., Holt, J.A., Pain, D., Stocco, D.M., Miller, W.L., Strauss, J.F. III, Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 13731–13736.
40. [40] Arakane, F., Kallen, C.B., Watari, H., Foster, J.A., Sepuri, N.B., Pain, D., Stayrook, S.E., Lewis, M., Gerton, G.L., Strauss, J.F. III, The mechanism of action of steroidogenic acute regulatory protein (StAR). StAR acts on the outside of mitochondria to stimulate steroidogenesis. J. Biol. Chem. 273 (1998), 16339–16345.
41. [41] Bose, H.S., Lingappa, V.R., Miller, W.L., The steroidogenic acute regulatory protein, StAR, works only at the outer mitochondrial membrane. Endocr. Res. 28 (2002), 295–308.
42. [42] Sasaki, G., Ishii, T., Jeyasuria, P., Jo, Y., Bahat, A., Orly, J., Hasegawa, T., Parker, K.L., Complex role of the mitochondrial targeting signal in the function of steroidogenic acute regulatory protein revealed by bacterial artificial chromosome transgenesis in vivo. Mol. Endocrinol. 22 (2008), 951–964.
43. [43] Artemenko, I.P., Zhao, D., Hales, D.B., Hales, K.H., Jefcoate, C.R., Mitochondrial processing of newly synthesized steroidogenic acute regulatory protein (StAR), but not total StAR, mediates cholesterol transfer to cytochrome P450 side chain cleavage enzyme in adrenal cells. J. Biol. Chem. 276 (2001), 46583–46596.
44. [44] Tuckey, R.C., Headlam, M.J., Bose, H.S., Miller, W.L., Transfer of cholesterol between phospholipid vesicles mediated by the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 277 (2002), 47123–47128.
45. [45] Mukhin, A.G., Papadopoulos, V., Costa, E., Krueger, K.E., Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 9813–9816.
46. [46] Papadopoulos, V., Mukhin, A.G., Costa, E., Krueger, K.E., The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265 (1990), 3772–3779.
47. [47] Papadopoulos, V., Amri, H., Li, H., Boujrad, N., Vidic, B., Garnier, M., Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 272 (1997), 32129–32135.
48. [48] Hauet, T., Yao, Z.X., Bose, H.S., Wall, C.T., Han, Z., Li, W., Hales, D.B., Miller, W.L., Culty, M., Papadopoulos, V., Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol. Endocrinol. 19 (2005), 540–554.
49. [49] Lacapere, J.J., Papadopoulos, V., Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68 (2003), 569–585.
50. [50] Li, H., Yao, Z., Degenhardt, B., Teper, G., Papadopoulos, V., Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 1267–1272.
51. [51] Jamin, N., Neumann, J.M., Ostuni, M.A., Vu, T.K., Yao, Z.X., Murail, S., Robert, J.C., Giatzakis, C., Papadopoulos, V., Lacapere, J.J., Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19 (2005), 588–594.
52. [52] Fantini, J., Di Scala, C., Baier, C.J., Barrantes, F.J., Molecular mechanisms of protein-cholesterol interactions in plasma membranes: functional distinction between topological (tilted) and consensus (CARC/CRAC) domains. Chem. Phys. Lipids, 2016.
53. [53] Culty, M., Li, H., Boujrad, N., Amri, H., Vidic, B., Bernassau, J.M., Reversat, J.L., Papadopoulos, V., In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis. J. Steroid Biochem. Mol. Biol. 69 (1999), 123–130.
54. [54] Delavoie, F., Li, H., Hardwick, M., Robert, J.C., Giatzakis, C., Peranzi, G., Yao, Z.X., Maccario, J., Lacapere, J.J., Papadopoulos, V., In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42 (2003), 4506–4519.
55. [55] Fantini, J., Di Scala, C., Evans, L.S., Williamson, P.T., Barrantes, F.J., A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes. Sci. Rep., 6, 2016, 21907.
56. [56] McEnery, M.W., Snowman, A.M., Trifiletti, R.R., Snyder, S.H., Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 3170–3174.
57. [57] Liu, J., Rone, M.B., Papadopoulos, V., Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem. 281 (2006), 38879–38893.
58. [58] Rone, M.B., Fan, J., Papadopoulos, V., Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta 1791 (2009), 646–658.
59. [59] Rone, M.B., Midzak, A.S., Issop, L., Rammouz, G., Jagannathan, S., Fan, J., Ye, X., Blonder, J., Veenstra, T., Papadopoulos, V., Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol. Endocrinol. 26 (2012), 1868–1882.
60. [60] Hubstenberger, A., Merle, N., Charton, R., Brandolin, G., Rousseau, D., Topological analysis of ATAD3A insertion in purified human mitochondria. J. Bioenerg. Biomembr. 42 (2010), 143–150.
61. [61] Gilquin, B., Taillebourg, E., Cherradi, N., Hubstenberger, A., Gay, O., Merle, N., Assard, N., Fauvarque, M.O., Tomohiro, S., Kuge, O., Baudier, J., The AAA + ATPase ATAD3A controls mitochondrial dynamics at the interface of the inner and outer membranes. Mol. Cell. Biol. 30 (2010), 1984–1996.
62. [62] Issop, L., Rone, M.B., Papadopoulos, V., Organelle plasticity and interactions in cholesterol transport and steroid biosynthesis. Mol. Cell. Endocrinol., 2012.
63. [63] Bose, M., Whittal, R.M., Miller, W.L., Bose, H.S., Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. J. Biol. Chem. 283 (2008), 8837–8845.
64. [64] West, L.A., Horvat, R.D., Roess, D.A., Barisas, B.G., Juengel, J.L., Niswender, G.D., Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology 142 (2001), 502–505.
65. [65] Bogan, R.L., Davis, T.L., Niswender, G.D., Peripheral-type benzodiazepine receptor (PBR) aggregation and absence of steroidogenic acute regulatory protein (StAR)/PBR association in the mitochondrial membrane as determined by bioluminescence resonance energy transfer (BRET). J. Steroid Biochem. Mol. Biol. 104 (2007), 61–67.
66. [66] Morohaku, K., Pelton, S.H., Daugherty, D.J., Butler, W.R., Deng, W., Selvaraj, V., Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155 (2014), 89–97.
67. [67] Tu, L.N., Zhao, A.H., Stocco, D.M., Selvaraj, V., PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO). Endocrinology 156 (2015), 1033–1039.
68. [68] Fan, J., Campioli, E., Midzak, A., Culty, M., Papadopoulos, V., Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 7261–7266.
69. [69] Tu, L.N., Morohaku, K., Manna, P.R., Pelton, S.H., Butler, W.R., Stocco, D.M., Selvaraj, V., Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 289 (2014), 27444–27454.
70. [70] Banati, R.B., Middleton, R.J., Chan, R., Hatty, C.R., Kam, W.W., Quin, C., Graeber, M.B., Parmar, A., Zahra, D., Callaghan, P., Fok, S., Howell, N.R., Gregoire, M., Szabo, A., Pham, T., Davis, E., Liu, G.J., Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun., 5, 2014, 5452.
71. [71] Selvaraj, V., Stocco, D.M., Tu, L.N., Minireview: translocator protein (TSPO) and steroidogenesis: a reappraisal. Mol. Endocrinol. 29 (2015), 490–501.
72. [72] Selvaraj, V., Stocco, D.M., The changing landscape in translocator protein (TSPO) function. Trends Endocrinol. Metab. 26 (2015), 341–348.
73. [73] Midzak, A., Zirkin, B., Papadopoulos, V., Translocator protein: pharmacology and steroidogenesis. Biochem. Soc. Trans. 43 (2015), 572–578.
74. [74] Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B., Midzak, A., Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol. Cell. Endocrinol. 408 (2015), 90–98.
75. [75] Kraemer, F.B., Khor, V.K., Shen, W.J., Azhar, S., Cholesterol ester droplets and steroidogenesis. Mol. Cell. Endocrinol. 371 (2013), 15–19.
76. [76] Lange, Y., Steck, T.L., Ye, J., Lanier, M.H., Molugu, V., Ory, D., Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. J. Lipid Res. 50 (2009), 1881–1888.
77. [77] Charman, M., Kennedy, B.E., Osborne, N., Karten, B., MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick type C1 protein. J. Lipid Res. 51 (2010), 1023–1034.
78. [78] Kennedy, B.E., Charman, M., Karten, B., Niemann-Pick type C2 protein contributes to the transport of endosomal cholesterol to mitochondria without interacting with NPC1. J. Lipid Res. 53 (2012), 2632–2642.
79. [79] Dimmer, K.S., Rapaport, D., Mitochondrial contact sites as platforms for phospholipid exchange. Biochim. Biophys. Acta 1862 (2017), 69–80.
80. [80] Mesmin, B., Maxfield, F.R., Intracellular sterol dynamics. Biochim. Biophys. Acta 1791 (2009), 636–645.
81. [81] Lahiri, S., Toulmay, A., Prinz, W.A., Membrane contact sites, gateways for lipid homeostasis. Curr. Opin. Cell Biol. 33 (2015), 82–87.
82. [82] Helle, S.C., Kanfer, G., Kolar, K., Lang, A., Michel, A.H., Kornmann, B., Organization and function of membrane contact sites. Biochim. Biophys. Acta 1833 (2013), 2526–2541.
83. [83] Quon, E., Beh, C.T., Membrane contact sites: complex zones for membrane association and lipid exchange. Lipid Insights 8 (2016), 55–63.
84. [84] Lev, S., Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat. Rev. Mol. Cell Biol. 11 (2010), 739–750.
85. [85] Sugiura, A., McLelland, G.L., Fon, E.A., McBride, H.M., A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 33 (2014), 2142–2156.
86. [86] Scharwey, M., Tatsuta, T., Langer, T., Mitochondrial lipid transport at a glance. J. Cell Sci. 126 (2013), 5317–5323.
87. [87] Tatsuta, T., Scharwey, M., Langer, T., Mitochondrial lipid trafficking. Trends Cell Biol. 24 (2014), 44–52.
88. [88] Mesmin, B., Mitochondrial lipid transport and biosynthesis: a complex balance. J. Cell Biol. 214 (2016), 9–11.
89. [89] Tamura, Y., Sesaki, H., Endo, T., Phospholipid transport via mitochondria. Traffic 15 (2014), 933–945.
90. [90] Romanowski, M.J., Soccio, R.E., Breslow, J.L., Burley, S.K., Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 6949–6954.
91. [91] Thorsell, A.G., Lee, W.H., Persson, C., Siponen, M.I., Nilsson, M., Busam, R.D., Kotenyova, T., Schuler, H., Lehtio, L., Comparative structural analysis of lipid binding START domains. PLoS One, 6, 2011, e19521.
92. [92] Iaea, D.B., Dikiy, I., Kiburu, I., Eliezer, D., Maxfield, F.R., STARD4 membrane interactions and sterol binding. Biochemistry 54 (2015), 4623–4636.
93. [93] Mathieu, A.P., Fleury, A., Ducharme, L., Lavigne, P., LeHoux, J.G., Insights into steroidogenic acute regulatory protein (StAR)-dependent cholesterol transfer in mitochondria: evidence from molecular modeling and structure-based thermodynamics supporting the existence of partially unfolded states of StAR. J. Mol. Endocrinol. 29 (2002), 327–345.
94. [94] Mathieu, A.P., Lavigne, P., LeHoux, J.G., Molecular modeling and structure-based thermodynamic analysis of the StAR protein. Endocr. Res. 28 (2002), 419–423.
95. [95] Roostaee, A., Barbar, E., Lavigne, P., LeHoux, J.G., The mechanism of specific binding of free cholesterol by the steroidogenic acute regulatory protein: evidence for a role of the C-terminal alpha-helix in the gating of the binding site. Biosci. Rep. 29 (2009), 89–101.
96. [96] Roostaee, A., Barbar, E., Lehoux, J.G., Lavigne, P., Cholesterol binding is a prerequisite for the activity of the steroidogenic acute regulatory protein (StAR). Biochem. J. 412 (2008), 553–562.
97. [97] Tuckey, R.C., Bose, H.S., Czerwionka, I., Miller, W.L., Molten globule structure and steroidogenic activity of N-218 MLN64 in human placental mitochondria. Endocrinology 145 (2004), 1700–1707.
98. [98] Bose, H.S., Baldwin, M.A., Miller, W.L., Evidence that StAR and MLN64 act on the outer mitochondrial membrane as molten globules. Endocr. Res. 26 (2000), 629–637.
99. [99] Bose, H.S., Whittal, R.M., Ran, Y., Bose, M., Baker, B.Y., Miller, W.L., StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry 47 (2008), 2277–2288.
100. [100] Kallen, C.B., Billheimer, J.T., Summers, S.A., Stayrook, S.E., Lewis, M., Strauss, J.F. III, Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein. J. Biol. Chem. 273 (1998), 26285–26288.
101. [101] Soccio, R.E., Adams, R.M., Maxwell, K.N., Breslow, J.L., Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J. Biol. Chem. 280 (2005), 19410–19418.
102. [102] Watari, H., Arakane, F., Moog-Lutz, C., Kallen, C.B., Tomasetto, C., Gerton, G.L., Rio, M.C., Baker, M.E., Strauss, J.F. III, MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 8462–8467.
103. [103] Bose, H.S., Whittal, R.M., Huang, M.C., Baldwin, M.A., Miller, W.L., N-218 MLN64, a protein with StAR-like steroidogenic activity, is folded and cleaved similarly to StAR. Biochemistry 39 (2000), 11722–11731.
104. [104] Weber-Boyvat, M., Zhong, W., Yan, D., Olkkonen, V.M., Oxysterol-binding proteins: functions in cell regulation beyond lipid metabolism. Biochem. Pharmacol. 86 (2013), 89–95.
105. [105] Villasmil, M.L., Bankaitis, V.A., Mousley, C.J., The oxysterol-binding protein superfamily: new concepts and old proteins. Biochem. Soc. Trans. 40 (2012), 469–473.
106. [106] Ngo, M.H., Colbourne, T.R., Ridgway, N.D., Functional implications of sterol transport by the oxysterol-binding protein gene family. Biochem. J. 429 (2010), 13–24.
107. [107] Tong, J., Manik, M.K., Yang, H., Im, Y.J., Structural insights into nonvesicular lipid transport by the oxysterol binding protein homologue family. Biochim. Biophys. Acta 1861 (2016), 928–939.
108. [108] Olkkonen, V.M., Li, S., Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog. Lipid Res. 52 (2013), 529–538.
109. [109] Mesmin, B., Antonny, B., The counterflow transport of sterols and PI4P. Biochim. Biophys. Acta 1861 (2016), 940–951.
110. [110] Suchanek, M., Hynynen, R., Wohlfahrt, G., Lehto, M., Johansson, M., Saarinen, H., Radzikowska, A., Thiele, C., Olkkonen, V.M., The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem. J. 405 (2007), 473–480.
111. [111] Maeda, K., Anand, K., Chiapparino, A., Kumar, A., Poletto, M., Kaksonen, M., Gavin, A.C., Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. Nature 501 (2013), 257–261.
112. [112] Goto, A., Liu, X., Robinson, C.A., Ridgway, N.D., Multisite phosphorylation of oxysterol-binding protein regulates sterol binding and activation of sphingomyelin synthesis. Mol. Biol. Cell 23 (2012), 3624–3635.
113. [113] Goto, A., Charman, M., Ridgway, N.D., Oxysterol-binding protein activation at endoplasmic reticulum-Golgi contact sites reorganizes phosphatidylinositol 4-phosphate pools. J. Biol. Chem. 291 (2016), 1336–1347.
114. [114] Galmes, R., Houcine, A., van Vliet, A.R., Agostinis, P., Jackson, C.L., Giordano, F., ORP5/ORP8 localize to endoplasmic reticulum-mitochondria contacts and are involved in mitochondrial function. EMBO Rep. 17 (2016), 800–810.
115. [115] Rusinol, A.E., Cui, Z., Chen, M.H., Vance, J.E., A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269 (1994), 27494–27502.
116. [116] Vance, J.E., MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim. Biophys. Acta 1841 (2014), 595–609.
117. [117] van Vliet, A.R., Verfaillie, T., Agostinis, P., New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta, 2014.
118. [118] Raturi, A., Simmen, T., Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim. Biophys. Acta 1833 (2013), 213–224.
119. [119] Grimm, S., The ER-mitochondria interface: the social network of cell death. Biochim. Biophys. Acta 1823 (2012), 327–334.
120. [120] Giorgi, C., Missiroli, S., Patergnani, S., Duszynski, J., Wieckowski, M.R., Pinton, P., Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid. Redox Signal. 22 (2015), 995–1019.
121. [121] Shiao, Y.J., Lupo, G., Vance, J.E., Evidence that phosphatidylserine is imported into mitochondria via a mitochondria-associated membrane and that the majority of mitochondrial phosphatidylethanolamine is derived from decarboxylation of phosphatidylserine. J. Biol. Chem. 270 (1995), 11190–11198.
122. [122] Shiao, Y.J., Balcerzak, B., Vance, J.E., A mitochondrial membrane protein is required for translocation of phosphatidylserine from mitochondria-associated membranes to mitochondria. Biochem. J. 331:Pt 1 (1998), 217–223.
123. [123] Stone, S.J., Vance, J.E., Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J. Biol. Chem. 275 (2000), 34534–34540.
124. [124] Kannan, M., Riekhof, W.R., Voelker, D.R., Transport of phosphatidylserine from the endoplasmic reticulum to the site of phosphatidylserine decarboxylase2 in yeast. Traffic 16 (2015), 123–134.
125. [125] Area-Gomez, E., Del Carmen Lara Castillo, M., Tambini, M.D., Guardia-Laguarta, C., de Groof, A.J., Madra, M., Ikenouchi, J., Umeda, M., Bird, T.D., Sturley, S.L., Schon, E.A., Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31 (2012), 4106–4123.
126. [126] Fujimoto, M., Hayashi, T., Su, T.P., The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria. Biochem. Biophys. Res. Commun. 417 (2012), 635–639.
127. [127] Kornmann, B., Currie, E., Collins, S.R., Schuldiner, M., Nunnari, J., Weissman, J.S., Walter, P., An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science 325 (2009), 477–481.
128. [128] Lang, A., John Peter, A.T., Kornmann, B., ER-mitochondria contact sites in yeast: beyond the myths of ERMES. Curr. Opin. Cell Biol. 35 (2015), 7–12.
129. [129] Lahiri, S., Chao, J.T., Tavassoli, S., Wong, A.K., Choudhary, V., Young, B.P., Loewen, C.J., Prinz, W.A., A conserved endoplasmic reticulum membrane protein complex (EMC) facilitates phospholipid transfer from the ER to mitochondria. PLoS Biol., 12, 2014, e1001969.
130. [130] Tan, T., Ozbalci, C., Brugger, B., Rapaport, D., Dimmer, K.S., Mcp1 and Mcp2, two novel proteins involved in mitochondrial lipid homeostasis. J. Cell Sci. 126 (2013), 3563–3574.
131. [131] Voss, C., Lahiri, S., Young, B.P., Loewen, C.J., Prinz, W.A., ER-shaping proteins facilitate lipid exchange between the ER and mitochondria in S. cerevisiae. J. Cell Sci. 125 (2012), 4791–4799.
132. [132] AhYoung, A.P., Jiang, J., Zhang, J., Khoi Dang, X., Loo, J.A., Zhou, Z.H., Egea, P.F., Conserved SMP domains of the ERMES complex bind phospholipids and mediate tether assembly. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E3179–E3188.
133. [133] Kojima, R., Endo, T., Tamura, Y., A phospholipid transfer function of ER-mitochondria encounter structure revealed in vitro. Sci. Rep., 6, 2016, 30777.
134. [134] Watanabe, Y., Tamura, Y., Kawano, S., Endo, T., Structural and mechanistic insights into phospholipid transfer by Ups1-Mdm35 in mitochondria. Nat. Commun., 6, 2015, 7922.
135. [135] Miyata, N., Watanabe, Y., Tamura, Y., Endo, T., Kuge, O., Phosphatidylserine transport by Ups2-Mdm35 in respiration-active mitochondria. J. Cell Biol. 214 (2016), 77–88.
136. [136] Kopec, K.O., Alva, V., Lupas, A.N., Homology of SMP domains to the TULIP superfamily of lipid-binding proteins provides a structural basis for lipid exchange between ER and mitochondria. Bioinformatics 26 (2010), 1927–1931.
137. [137] Elbaz-Alon, Y., Eisenberg-Bord, M., Shinder, V., Stiller, S.B., Shimoni, E., Wiedemann, N., Geiger, T., Schuldiner, M., Lam6 regulates the extent of contacts between organelles. Cell Rep. 12 (2015), 7–14.
138. [138] Duarte, A., Poderoso, C., Cooke, M., Soria, G., Cornejo Maciel, F., Gottifredi, V., Podesta, E.J., Mitochondrial fusion is essential for steroid biosynthesis. PLoS One, 7, 2012, e45829.
139. [139] Issop, L., Fan, J., Lee, S., Rone, M.B., Basu, K., Mui, J., Papadopoulos, V., Mitochondria-associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: role of ATAD3. Endocrinology 156 (2015), 334–345.
140. [140] Marriott, K.S., Prasad, M., Thapliyal, V., Bose, H.S., Sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation. J. Pharmacol. Exp. Ther. 343 (2012), 578–586.
141. [141] Prasad, M., Kaur, J., Pawlak, K.J., Bose, M., Whittal, R.M., Bose, H.S., Mitochondria-associated endoplasmic reticulum membrane (MAM) regulates steroidogenic activity via steroidogenic acute regulatory protein (StAR)-voltage-dependent Anion Channel 2 (VDAC2) interaction. J. Biol. Chem. 290 (2015), 2604–2616.
142. [142] Montero, J., Morales, A., Llacuna, L., Lluis, J.M., Terrones, O., Basanez, G., Antonsson, B., Prieto, J., Garcia-Ruiz, C., Colell, A., Fernandez-Checa, J.C., Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res. 68 (2008), 5246–5256.
143. [143] Morales, A., Mari, M., Garcia-Ruiz, C., Colell, A., Fernandez-Checa, J.C., Hepatocarcinogenesis and ceramide/cholesterol metabolism. Anti Cancer Agents Med. Chem., 2011.
144. [144] Barbero-Camps, E., Fernandez, A., Baulies, A., Martinez, L., Fernandez-Checa, J.C., Colell, A., Endoplasmic reticulum stress mediates amyloid beta neurotoxicity via mitochondrial cholesterol trafficking. Am. J. Pathol. 184 (2014), 2066–2081.
145. [145] Barbero-Camps, E., Fernandez, A., Martinez, L., Fernandez-Checa, J.C., Colell, A., APP/PS1 mice overexpressing SREBP-2 exhibit combined Abeta accumulation and tau pathology underlying Alzheimer's disease. Hum. Mol. Genet. 22 (2013), 3460–3476.
146. [146] Fernandez, A., Llacuna, L., Fernandez-Checa, J.C., Colell, A., Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J. Neurosci. 29 (2009), 6394–6405.
147. [147] Baker, B.Y., Epand, R.F., Epand, R.M., Miller, W.L., Cholesterol binding does not predict activity of the steroidogenic acute regulatory protein, StAR. J. Biol. Chem. 282 (2007), 10223–10232.
148. [148] Goodman, J.M., The gregarious lipid droplet. J. Biol. Chem. 283 (2008), 28005–28009.
149. [149] Murphy, S., Martin, S., Parton, R.G., Lipid droplet-organelle interactions; sharing the fats. Biochim. Biophys. Acta 1791 (2009), 441–447.
150. [150] Zehmer, J.K., Huang, Y., Peng, G., Pu, J., Anderson, R.G., Liu, P., A role for lipid droplets in inter-membrane lipid traffic. Proteomics 9 (2009), 914–921.
151. [151] Crivello, J.F., Jefcoate, C.R., Intracellular movement of cholesterol in rat adrenal cells. Kinetics and effects of inhibitors. J. Biol. Chem. 255 (1980), 8144–8151.
152. [152] Soto, E.A., Kliman, H.J., Strauss, J.F. III, Paavola, L.G., Gonadotropins and cyclic adenosine 3′,5′-monophosphate (cAMP) alter the morphology of cultured human granulosa cells. Biol. Reprod. 34 (1986), 559–569.
153. [153] Almahbobi, G., Williams, L.J., Hall, P.F., Attachment of mitochondria to intermediate filaments in adrenal cells: relevance to the regulation of steroid synthesis. Exp. Cell Res. 200 (1992), 361–369.
154. [154] Almahbobi, G., Williams, L.J., Han, X.G., Hall, P.F., Binding of lipid droplets and mitochondria to intermediate filaments in rat Leydig cells. J. Reprod. Fertil. 98 (1993), 209–217.
155. [155] Merry, B.J., Mitochondrial structure in the rat adrenal cortex. J. Anat. 119 (1975), 611–618.
156. [156] Sturmey, R.G., O'Toole, P.J., Leese, H.J., Fluorescence resonance energy transfer analysis of mitochondrial:lipid association in the porcine oocyte. Reproduction 132 (2006), 829–837.
157. [157] Lin, Y., Hou, X., Shen, W.J., Hanssen, R., Khor, V.K., Cortez, Y., Roseman, A.N., Azhar, S., Kraemer, F.B., SNARE-mediated cholesterol movement to mitochondria supports steroidogenesis in rodent cells. Mol. Endocrinol. 30 (2016), 234–247.
158. [158] Honscher, C., Mari, M., Auffarth, K., Bohnert, M., Griffith, J., Geerts, W., van der Laan, M., Cabrera, M., Reggiori, F., Ungermann, C., Cellular metabolism regulates contact sites between vacuoles and mitochondria. Dev. Cell 30 (2014), 86–94.
159. [159] Elbaz-Alon, Y., Rosenfeld-Gur, E., Shinder, V., Futerman, A.H., Geiger, T., Schuldiner, M., A dynamic interface between vacuoles and mitochondria in yeast. Dev. Cell 30 (2014), 95–102.
160. [160] Sheftel, A.D., Zhang, A.S., Brown, C., Shirihai, O.S., Ponka, P., Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110 (2007), 125–132.
161. [161] Daniele, T., Hurbain, I., Vago, R., Casari, G., Raposo, G., Tacchetti, C., Schiaffino, M.V., Mitochondria and melanosomes establish physical contacts modulated by Mfn2 and involved in organelle biogenesis. Curr. Biol. 24 (2014), 393–403.
162. [162] Huotari, J., Helenius, A., Endosome maturation. EMBO J. 30 (2011), 3481–3500.
163. [163] Rosenbaum, A.I., Maxfield, F.R., Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J. Neurochem. 116 (2011), 789–795.
164. [164] Mukherjee, S., Maxfield, F.R., Lipid and cholesterol trafficking in NPC. Biochim. Biophys. Acta 1685 (2004), 28–37.
165. [165] Vance, J.E., Karten, B., Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin. J. Lipid Res. 55 (2014), 1609–1621.
166. [166] Karten, B., Peake, K.B., Vance, J.E., Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Biochim. Biophys. Acta 1791 (2009), 659–670.
167. [167] Ory, D.S., The niemann-pick disease genes; regulators of cellular cholesterol homeostasis. Trends Cardiovasc. Med. 14 (2004), 66–72.
168. [168] Storch, J., Xu, Z., Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking. Biochim. Biophys. Acta 1791 (2009), 671–678.
169. [169] Alpy, F., Stoeckel, M.E., Dierich, A., Escola, J.M., Wendling, C., Chenard, M.P., Vanier, M.T., Gruenberg, J., Tomasetto, C., Rio, M.C., The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J. Biol. Chem. 276 (2001), 4261–4269.
170. [170] Moog-Lutz, C., Tomasetto, C., Regnier, C.H., Wendling, C., Lutz, Y., Muller, D., Chenard, M.P., Basset, P., Rio, M.C., MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int. J. Cancer 71 (1997), 183–191.
171. [171] Alpy, F., Latchumanan, V.K., Kedinger, V., Janoshazi, A., Thiele, C., Wendling, C., Rio, M.C., Tomasetto, C., Functional characterization of the MENTAL domain. J. Biol. Chem. 280 (2005), 17945–17952.
172. [172] Wilhelm, L.P., Tomasetto, C., Alpy, F., Touche! STARD3 and STARD3NL tether the ER to endosomes. Biochem. Soc. Trans. 44 (2016), 493–498.
173. [173] Alpy, F., Rousseau, A., Schwab, Y., Legueux, F., Stoll, I., Wendling, C., Spiegelhalter, C., Kessler, P., Mathelin, C., Rio, M.C., Levine, T.P., Tomasetto, C., STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER. J. Cell Sci. 126 (2013), 5500–5512.
174. [174] Alpy, F., Wendling, C., Rio, M.C., Tomasetto, C., MENTHO, a MLN64 homologue devoid of the START domain. J. Biol. Chem. 277 (2002), 50780–50787.
175. [175] Holtta-Vuori, M., Alpy, F., Tanhuanpaa, K., Jokitalo, E., Mutka, A.L., Ikonen, E., MLN64 is involved in actin-mediated dynamics of late endocytic organelles. Mol. Biol. Cell 16 (2005), 3873–3886.
176. [176] Liapis, A., Chen, F.W., Davies, J.P., Wang, R., Ioannou, Y.A., MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site. PLoS One, 7, 2012, e34424.
177. [177] Kishida, T., Kostetskii, I., Zhang, Z., Martinez, F., Liu, P., Walkley, S.U., Dwyer, N.K., Blanchette-Mackie, E.J., Radice, G.L., Strauss, J.F. III, Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J. Biol. Chem. 279 (2004), 19276–19285.
178. [178] Borthwick, F., Allen, A.M., Taylor, J.M., Graham, A., Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype. Clin. Sci. (Lond.) 119 (2010), 265–272.
179. [179] Zhang, M., Liu, P., Dwyer, N.K., Christenson, L.K., Fujimoto, T., Martinez, F., Comly, M., Hanover, J.A., Blanchette-Mackie, E.J., Strauss, J.F. III, MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 277 (2002), 33300–33310.
180. [180] van der Kant, R., Zondervan, I., Janssen, L., Neefjes, J., Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1. J. Lipid Res. 54 (2013), 2153–2165.
181. [181] Ha, S.D., Park, S., Han, C.Y., Nguyen, M.L., Kim, S.O., Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 in macrophages. Mol. Cell. Biol. 32 (2012), 4846–4860.
182. [182] Strauss, J.F. 3rd, Christenson, L.K., Devoto, L., Martinez, F., Providing progesterone for pregnancy: Control of cholesterol flux to the side-chain cleavage system. J. Reprod. Fertil. Suppl. 55 (2000), 3–12.
183. [183] van Leusden, H.A., Thomas, C., Telegdy, G., Diczfalusy, E., Lack of squalene and lanosterol synthesis by the perfused human placenta at term. J. Steroid Biochem. 4 (1973), 349–354.
184. [184] Sanderson, J.T., Placental and fetal steroidogenesis. Methods Mol. Biol. 550 (2009), 127–136.
185. [185] Winkel, C.A., MacDonald, P.C., Hemsell, P.G., Simpson, E.R., Regulation of cholesterol metabolism by human trophoblastic cells in primary culture. Endocrinology 109 (1981), 1084–1090.
186. [186] Winkel, C.A., MacDonald, P.C., Simpson, E.R., The role of receptor-mediated low-density lipoprotein uptake and degradation in the regulation of progesterone biosynthesis and cholesterol metabolism by human trophoblasts. Placenta(Suppl. 3), 1981, 133–143.
187. [187] Wadsack, C., Hammer, A., Levak-Frank, S., Desoye, G., Kozarsky, K.F., Hirschmugl, B., Sattler, W., Malle, E., Selective cholesteryl ester uptake from high density lipoprotein by human first trimester and term villous trophoblast cells. Placenta 24 (2003), 131–143.
188. [188] Uribe, A., Strauss, J.F. III, Martinez, F., Contact sites from human placental mitochondria: characterization and role in progesterone synthesis. Arch. Biochem. Biophys. 413 (2003), 172–181.
189. [189] Olvera-Sanchez, S., Espinosa-Garcia, M.T., Monreal, J., Flores-Herrera, O., Martinez, F., Mitochondrial heat shock protein participates in placental steroidogenesis. Placenta 32 (2011), 222–229.
190. [190] Esparza-Perusquia, M., Olvera-Sanchez, S., Flores-Herrera, O., Flores-Herrera, H., Guevara-Flores, A., Pardo, J.P., Espinosa-Garcia, M.T., Martinez, F., Mitochondrial proteases act on STARD3 to activate progesterone synthesis in human syncytiotrophoblast. Biochim. Biophys. Acta 1850 (2015), 107–117.
191. [191] Slominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C., Tuckey, R.C., A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur. J. Biochem. 271 (2004), 4178–4188.
192. [192] Garbarino, J., Pan, M., Chin, H.F., Lund, F.W., Maxfield, F.R., Breslow, J.L., STARD4 knockdown in HepG2 cells disrupts cholesterol trafficking associated with the plasma membrane, ER, and ERC. J. Lipid Res. 53 (2012), 2716–2725.
193. [193] Rodriguez-Agudo, D., Ren, S., Wong, E., Marques, D., Redford, K., Gil, G., Hylemon, P., Pandak, W.M., Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J. Lipid Res. 49 (2008), 1409–1419.
194. [194] Mesmin, B., Pipalia, N.H., Lund, F.W., Ramlall, T.F., Sokolov, A., Eliezer, D., Maxfield, F.R., STARD4 abundance regulates sterol transport and sensing. Mol. Biol. Cell 22 (2011), 4004–4015.
195. [195] Riegelhaupt, J.J., Waase, M.P., Garbarino, J., Cruz, D.E., Breslow, J.L., Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. J. Lipid Res. 51 (2010), 1134–1143.
196. [196] Letourneau, D., Lefebvre, A., Lavigne, P., LeHoux, J.G., STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies. Mol. Cell. Endocrinol. 371 (2013), 20–25.
197. [197] Letourneau, D., Lorin, A., Lefebvre, A., Cabana, J., Lavigne, P., LeHoux, J.G., Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim. Biophys. Acta 1831 (2013), 1589–1599.
198. [198] Soccio, R.E., Adams, R.M., Romanowski, M.J., Sehayek, E., Burley, S.K., Breslow, J.L., The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 6943–6948.
199. [199] Gomes, C., Oh, S.D., Kim, J.W., Chun, S.Y., Lee, K., Kwon, H.B., Soh, J., Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol. Reprod. 72 (2005), 651–658.
200. [200] LaVoie, H.A., Whitfield, N.E., Shi, B., King, S.R., Bose, H.S., Hui, Y.Y., STARD6 is expressed in steroidogenic cells of the ovary and can enhance de novo steroidogenesis. Exp. Biol. Med. (Maywood) 239 (2014), 430–435.
201. [201] Chang, I.Y., Kim, J.H., Cho, K.W., Yoon, S.P., Acute responses of DNA repair proteins and StarD6 in rat hippocampus after domoic acid-induced excitotoxicity. Acta Histochem. 115 (2013), 234–239.
202. [202] Chang, I.Y., Jeon, Y.J., Jung, S.M., Jang, Y.H., Ahn, J.B., Park, K.S., Yoon, S.P., Does the StarD6 mark the same as the StAR in the nervous system?. J. Chem. Neuroanat. 40 (2010), 239–242.
203. [203] Chang, I.Y., Kim, J.K., Lee, S.M., Kim, J.N., Soh, J., Kim, J.W., Yoon, S.P., The changed immunoreactivity of StarD6 after pilocarpine-induced epilepsy. Neuroreport 20 (2009), 963–967.
204. [204] Baggetto, L.G., Clottes, E., Vial, C., Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells. Cancer Res. 52 (1992), 4935–4941.
205. [205] Colell, A., Garcia-Ruiz, C., Lluis, J.M., Coll, O., Mari, M., Fernandez-Checa, J.C., Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J. Biol. Chem. 278 (2003), 33928–33935.
206. [206] Paradis, S., Leoni, V., Caccia, C., Berdeaux, A., Morin, D., Cardioprotection by the TSPO ligand 4'-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion. Cardiovasc. Res. 98 (2013), 420–427.
207. [207] Bosch, M., Mari, M., Herms, A., Fernandez, A., Fajardo, A., Kassan, A., Giralt, A., Colell, A., Balgoma, D., Barbero, E., Gonzalez-Moreno, E., Matias, N., Tebar, F., Balsinde, J., Camps, M., Enrich, C., Gross, S.P., Garcia-Ruiz, C., Perez-Navarro, E., Fernandez-Checa, J.C., Pol, A., Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr. Biol. 21 (2011), 681–686.
208. [208] Coll, O., Colell, A., Garcia-Ruiz, C., Kaplowitz, N., Fernandez-Checa, J.C., Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology 38 (2003), 692–702.
209. [209] Parlo, R.A., Coleman, P.S., Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. J. Biol. Chem. 259 (1984), 9997–10003.
210. [210] Paradies, G., Petrosillo, G., Gadaleta, M.N., Ruggiero, F.M., The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett. 454 (1999), 207–209.
211. [211] Paradies, G., Ruggiero, F.M., Dinoi, P., Decreased activity of the phosphate carrier and modification of lipids in cardiac mitochondria from senescent rats. Int. J. Biochem. 24 (1992), 783–787.
212. [212] Dietzen, D.J., Davis, E.J., Excess membrane cholesterol is not responsible for metabolic and bioenergetic changes in AS-30D hepatoma mitochondria. Arch. Biochem. Biophys. 309 (1994), 341–347.
213. [213] Mari, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J.C., Garcia-Ruiz, C., Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4 (2006), 185–198.
214. [214] Lluis, J.M., Colell, A., Garcia-Ruiz, C., Kaplowitz, N., Fernandez-Checa, J.C., Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124 (2003), 708–724.
215. [215] Mei, S., Gu, H., Yang, X., Guo, H., Liu, Z., Cao, W., Prolonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes. Endocrinology 153 (2012), 2120–2129.
216. [216] Llacuna, L., Fernandez, A., Montfort, C.V., Matias, N., Martinez, L., Caballero, F., Rimola, A., Elena, M., Morales, A., Fernandez-Checa, J.C., Garcia-Ruiz, C., Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J. Hepatol. 54 (2011), 1002–1010.
217. [217] Lucken-Ardjomande, S., Montessuit, S., Martinou, J.C., Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes. Cell Death Differ. 15 (2008), 484–493.
218. [218] Echegoyen, S., Oliva, E.B., Sepulveda, J., Diaz-Zagoya, J.C., Espinosa-Garcia, M.T., Pardo, J.P., Martinez, F., Cholesterol increase in mitochondria: its effect on inner-membrane functions, submitochondrial localization and ultrastructural morphology. Biochem. J. 289:Pt 3 (1993), 703–708.
219. [219] Yu, W., Gong, J.S., Ko, M., Garver, W.S., Yanagisawa, K., Michikawa, M., Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem. 280 (2005), 11731–11739.
220. [220] Campbell, A.M., Chan, S.H., The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Arch. Biochem. Biophys. 466 (2007), 203–210.
221. [221] Rouslin, W., MacGee, J., Gupte, S., Wesselman, A., Epps, D.E., Mitochondrial cholesterol content and membrane properties in porcine myocardial ischemia. Am. J. Phys. 242 (1982), H254–H259.
222. [222] Kennedy, B.E., Madreiter, C.T., Vishnu, N., Malli, R., Graier, W.F., Karten, B., Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells. J. Biol. Chem., 2014.
223. [223] Maxfield, F.R., Mondal, M., Sterol and lipid trafficking in mammalian cells. Biochem. Soc. Trans. 34 (2006), 335–339.
224. [224] Maxfield, F.R., Menon, A.K., Intracellular sterol transport and distribution. Curr. Opin. Cell Biol. 18 (2006), 379–385.
225. [225] Holthuis, J.C., Menon, A.K., Lipid landscapes and pipelines in membrane homeostasis. Nature 510 (2014), 48–57.
226. [226] Sangeetha, T., Darlin Quine, S., Preventive effect of S-allyl cysteine sulphoxide (Alliin) on mitochondrial dysfunction in normal and isoproterenol induced cardiotoxicity in male Wistar rats: a histopathological study. Mol. Cell. Biochem. 328 (2009), 1–8.
227. [227] Colell, A., Garcia-Ruiz, C., Morales, A., Ballesta, A., Ookhtens, M., Rodes, J., Kaplowitz, N., Fernandez-Checa, J.C., Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine. Hepatology 26 (1997), 699–708.
228. [228] Paradies, G., Ruggiero, F.M., Petrosillo, G., Gadaleta, M.N., Quagliariello, E., The effect of aging and acetyl-L-carnitine on the function and on the lipid composition of rat heart mitochondria. Ann. N. Y. Acad. Sci. 717 (1994), 233–243.
229. [229] Paradies, G., Ruggiero, F.M., Effect of aging on the activity of the phosphate carrier and on the lipid composition in rat liver mitochondria. Arch. Biochem. Biophys. 284 (1991), 332–337.
230. [230] Paradies, G., Ruggiero, F.M., Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria. Biochim. Biophys. Acta 1016 (1990), 207–212.
231. [231] Bravo, R., Vicencio, J.M., Parra, V., Troncoso, R., Munoz, J.P., Bui, M., Quiroga, C., Rodriguez, A.E., Verdejo, H.E., Ferreira, J., Iglewski, M., Chiong, M., Simmen, T., Zorzano, A., Hill, J.A., Rothermel, B.A., Szabadkai, G., Lavandero, S., Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J. Cell Sci. 124 (2011), 2143–2152.
232. [232] Fernandez, A., Matias, N., Fucho, R., Ribas, V., Von Montfort, C., Nuno, N., Baulies, A., Martinez, L., Tarrats, N., Mari, M., Colell, A., Morales, A., Dubuquoy, L., Mathurin, P., Bataller, R., Caballeria, J., Elena, M., Balsinde, J., Kaplowitz, N., Garcia-Ruiz, C., Fernandez-Checa, J.C., ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J. Hepatol. 59 (2013), 805–813.
233. [233] Yamada, S., Yamaguchi, T., Hosoda, A., Iwawaki, T., Kohno, K., Regulation of human STARD4 gene expression under endoplasmic reticulum stress. Biochem. Biophys. Res. Commun. 343 (2006), 1079–1085.
234. [234] Rodriguez-Agudo, D., Calderon-Dominguez, M., Medina, M.A., Ren, S., Gil, G., Pandak, W.M., ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J. Lipid Res. 53 (2012), 2708–2715.
235. [235] Varatharajalu, R., Garige, M., Leckey, L.C., Arellanes-Robledo, J., Reyes-Gordillo, K., Shah, R., Lakshman, M.R., Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat. Am. J. Pathol. 184 (2014), 2035–2044.
236. [236] Gan, L.T., Van Rooyen, D.M., Koina, M.E., McCuskey, R.S., Teoh, N.C., Farrell, G.C., Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. J. Hepatol. 61 (2014), 1376–1384.
237. [237] Mohamed, A., Saavedra, L., Di Pardo, A., Sipione, S., Posse de Chaves, E., Beta-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. J. Neurosci. 32 (2012), 6490–6500.
238. [238] Parton, R.G., Hanzal-Bayer, M., Hancock, J.F., Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119 (2006), 787–796.
239. [239] Frank, P.G., Cheung, M.W., Pavlides, S., Llaverias, G., Park, D.S., Lisanti, M.P., Caveolin-1 and regulation of cellular cholesterol homeostasis. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H677–H686.
240. [240] Cheruku, S.R., Xu, Z., Dutia, R., Lobel, P., Storch, J., Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J. Biol. Chem. 281 (2006), 31594–31604.
241. [241] Wang, M.L., Motamed, M., Infante, R.E., Abi-Mosleh, L., Kwon, H.J., Brown, M.S., Goldstein, J.L., Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metab. 12 (2010), 166–173.
242. [242] Porter, F.D., Scherrer, D.E., Lanier, M.H., Langmade, S.J., Molugu, V., Gale, S.E., Olzeski, D., Sidhu, R., Dietzen, D.J., Fu, R., Wassif, C.A., Yanjanin, N.M., Marso, S.P., House, J., Vite, C., Schaffer, J.E., Ory, D.S., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med., 2, 2010, 56ra81.
243. [243] Cluzeau, C.V., Watkins-Chow, D.E., Fu, R., Borate, B., Yanjanin, N., Dail, M.K., Davidson, C.D., Walkley, S.U., Ory, D.S., Wassif, C.A., Pavan, W.J., Porter, F.D., Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum. Mol. Genet. 21 (2012), 3632–3646.
244. [244] Vazquez, M.C., Balboa, E., Alvarez, A.R., Zanlungo, S., Oxidative stress: a pathogenic mechanism for Niemann-Pick type C disease. Oxidative Med. Cell. Longev., 2012, 2012, 205713.
245. [245] Fu, R., Yanjanin, N.M., Bianconi, S., Pavan, W.J., Porter, F.D., Oxidative stress in Niemann-Pick disease, type C. Mol. Genet. Metab. 101 (2010), 214–218.
246. [246] Kennedy, B.E., Leblanc, V.G., Mailman, T.M., Fice, D., Burton, I., Karakach, T.K., Karten, B., Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick type c1-deficient murine brain. PLoS One, 8, 2013, e82685.
247. [247] Kennedy, B.E., Hundert, A.S., Goguen, D., Weaver, I.C., Karten, B., Presymptomatic alterations in amino acid metabolism and DNA methylation in the cerebellum of a murine model of Niemann-Pick type C disease. Am. J. Pathol. 186 (2016), 1582–1597.
248. [248] Ordonez, M.P., Roberts, E.A., Kidwell, C.U., Yuan, S.H., Plaisted, W.C., Goldstein, L.S., Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Hum. Mol. Genet. 21 (2012), 2651–2662.